In February 2019, the Outline of the Development Plan for Guangdong, Hong Kong and Macao Greater Bay Area" was announced, and with the construction of the Guangdong, Hong Kong and Macao Greater Bay Area rising to a national strategy, Guangdong is facing major development opportunities across the region. In order to deeply implement the "Healthy China" strategy, comprehensively promote the construction of Guangdong, Hong Kong and Macao Bay Area, to meet the people's health service needs, to carry out reform experiments in the pharmaceutical and health system, and to promote the leapfrog development of Liwan pharmaceutical and health industry, combined with the actual pharmaceutical and health industry in Liwan District, to create a comprehensive pilot area for pharmaceutical and health in Guangdong, Hong Kong and Macao Bay Area ("the Pilot Zone"), which is the first of its kind in Guangdong Province. Hereinafter referred to as "test area"), the development of this program.
I. General Requirements
(a) Guiding Thought
Xi Jinping's thought of socialism with Chinese characteristics in the new era as a guide, comprehensively implement the 19th CPC National Congress and the 19th National Congress. Implement the spirit of the 19th CPC National Congress and the 2nd, 3rd and 4th Plenary Sessions of the 19th CPC Central Committee, implement the strategy of "Healthy China", take comprehensive deepening of reform, opening up and innovation as the driving force, take the pilot zone as an important hand in the construction of Guangdong, Hong Kong and Macao Bay Area, integrate the elemental resources of Guangdong, Hong Kong and Macao, and promote the medical treatment, pharmaceuticals, research, nourishment, health and tourism with the next-generation Internet, Artificial intelligence, big data, financial technology and other in-depth integration and development, to expand the all-round, full-cycle health industry chain, to build the pilot zone into an important support area for Guangzhou to realize the new vitality of the old city and the "four new colors", a demonstration area for Guangdong, Hong Kong and Macao pharmaceutical and health industry innovation and cooperation, and an important bearing area for the national strategy of revitalization of traditional Chinese medicine, to lead the development of pharmaceutical and health industry in the Greater Bay Area and even the whole country. It will lead the development of medicine and health industry in the Greater Bay Area and even the whole country.
(2) Functional Positioning
National Chinese Medicine Renaissance Strategy Carrying Zone. Relying on the advantages of Liwan's Chinese medicine industry, expanding the Chinese medicine industry chain, accelerating the optimization and upgrading of the Chinese medicine industry, and promoting the inheritance of Chinese medicine and the open and innovative development. Create a national TCM comprehensive reform pilot area, build a global TCM innovation center, carry out international exchanges and industrial cooperation in TCM healthcare for countries and regions along the "Belt and Road", and explore the development of a TCM industry standard system in line with international standards. The establishment of Chinese medicine overseas centers, accelerate the realization of China's traditional theories of Chinese medicine, Chinese medicine services and Chinese medicine culture to better serve the global development of Chinese medicine, and promote Lingnan Chinese medicine to the world.
Guangdong, Hong Kong and Macao Medicine and Health Innovation Cooperation Demonstration Zone. With the goal of promoting Guangdong, Hong Kong and Macao to build a world-class "Healthy Bay Area" and medical and healthcare community, we will focus on the quality medical and healthcare resources in the Greater Bay Area, and give full play to the advantages of the Pearl River Delta's market, industry and technology, as well as the advantages of Hong Kong and Macao in terms of talents, capital, technology and management, and take the lead in setting up a trans-regional medical and healthcare innovation and cooperation alliance. Explore the new system, mode and path of pharmaceutical and healthcare innovation cooperation among the three places with flexible cooperation methods, diversified cooperation subjects and smooth cooperation channels, and help realize the in-depth cooperation and innovative development of Guangdong, Hong Kong and Macao in the fields of pharmaceutical science and technology development and healthcare service docking.
A new high ground for the development of pharmaceutical and healthcare industries in the Greater Bay Area. Actively integrate into the Guangzhou-Shenzhen-Hong Kong-Macao Science and Technology Innovation Corridor, promote the convergence of the pharmaceutical and healthcare industry chain, supply chain and value chain in Liwan, and form an important hub for the docking of pharmaceutical and healthcare on both the east and west sides of the Pearl River. Promote the deployment of pilot transfer and transformation of the results of the National Science and Technology Major Project for the Creation of Major New Drugs, and the construction of national key specialties, laboratories and new research and development institutions. Promote the integration and innovative development of medicine and health with new-generation information technology and artificial intelligence, and focus on the development of biotechnology drugs, new chemical pharmaceutical preparations, modern Chinese medicine, high-performance medical devices and high-end medical care. Making full use of global medical and healthcare resources, Liwan will become a source of medical innovation, a platform for the development and transformation of cutting-edge medical technologies, and an international high-end diagnostic and treatment center.
Global Pharmaceutical Trade Service Center. Taking advantage of the cultural heritage of the millennium commercial capital, we will focus on the development of the pharmaceutical trade and build an international pharmaceutical supply chain service center to allocate resources globally. We will build online and offline trading platforms for the pharmaceutical trade and logistics industry and Chinese medicine, and create price indexes and Guangdong indexes. Construction of medical equipment import and export service center, vigorously develop health management, conference and exhibition, headquarters economy, cultural experience, health tourism and other industries, to create an international health enterprise headquarters agglomeration area, Liwan will be based in Guangzhou, facing the whole country, radiating the world's global pharmaceutical business service center.
(3) Development Goals
By 2025, the initial formation of innovation-driven pharmaceutical and health manufacturing industry, a full range of full-cycle health services, cross-border integration of distinctive new forms, economic and social development to drive significant, high-quality medical resources and health products. significantly, the coverage of high-quality medical resources and health products will be further expanded, the application of new technologies such as intelligent medical care and life science and technology will be more extensive, new modes to meet the personalized needs of consumers will continue to emerge, and the development of the Chinese medicine industry will gain a leading edge, and the level of internationalization will be further enhanced. Gathered a number of strong innovative ability and strong international competitiveness of the pharmaceutical and health industry multinational enterprises, the formation of a number of pharmaceutical and health industry science and technology innovation and transformation and application of platforms, investment and financing platforms and platforms of openness and cooperation, the proportion of new forms of business has increased significantly, the attractiveness of the international and domestic health consumer market continues to grow, Liwan national economy, the strategic pillar industry situation initially established.
By 2030, life science and technology innovation, health industry development and business environment to reach the domestic first-class level, scientific and technological innovation and the ability to transfer and transform the results of the country's leading level of medicine and health intelligent manufacturing, new drug research and development, industrial innovation, big data and other areas of significant breakthroughs in the international competitiveness increased significantly. Medical and health services to reach the international leading level, international influence continues to improve, the formation of industrial integration and interaction, resource intensive sharing, complete service chain of the pharmaceutical and health industry clusters, the overall level of development in Guangdong, Hong Kong and Macao, the Greater Bay Area in the forefront.
(D) Overall layout
According to the overall economic and social development of Guangzhou and Liwan District, the overall layout of the city is centered on the development of the national Chinese medicine rejuvenation strategy carrying area, Guangdong, Hong Kong and Macao medicine and health innovation and cooperation demonstration area, the Greater Bay Area medicine and health industry development new high ground and global health industry development new high ground. The strategic positioning of the health industry development and global pharmaceutical trade center, combined with the pharmaceutical and health industry development base and resource allocation conditions, to build the Liwan test area "an island, a port, a belt and multiple clusters" of the spatial pattern.
Datansha International Health Island, the entire island area of 3.55 square kilometers, the village collective economic development land and commercial and financial land with a total planned floor area of more than 2 million square meters. Focusing on the high-end fields of medicine, treatment, research, health care and tourism, with the National Center for Respiratory Medicine (Guangdong), international high-end medical institutions to carry out medical services as the core, driving the development of intelligent medical care, rehabilitation medicine, third-party medical testing, health management, scientific research and training, old age and health, health tourism, as well as health finance and other industrial development, to create a center for international high-end medical services, health care combination of Lingnan characteristics of the leisure resort.
Guangzhou International Medical Port is located in Dongsha Street, Liwan District, north of Guangzhou Ring Road, south of Huan Cui North Road, east of Fangcun Avenue, adjacent to the Pearl River back channel, with a total planned construction area of 2 million square meters. It will build four functional zones, namely, Health Ark, Guangdong-Hong Kong-Macao International Health Cooperation Zone, Silicon Valley of TCM Innovation, and Smart Healthy Life Demonstration Zone, and make every effort to build a global-oriented portal and hub for the big health industry, a never-ending trade fair for the big health industry, an incubation and experiential platform for the modernization of the country's traditional Chinese medicine, and a destination for Guangdong, Hong Kong, and Macao's healthy medical tourism and life.
The industrial zone along the south bank of the Pearl River is connected to the Datansha International Health Eco-Island on the top and the Guangzhou International Pharmaceutical Port on the bottom. The "belt" connects "an island" and "a port", which includes modern service industry clusters such as Baigutan Industrial Financial Service Innovation Zone and Southern Central Enterprises Headquarter Clustering Zone, covering financial, science and technology, logistics, cultural and other industries. The industries and fields of finance, science and technology, logistics, culture and so on have become the strong support for the construction of the medicine and health pilot zone.
Multiple clusters include the modern TCM cluster centered on traditional pharmaceutical enterprises such as Guangzhou Pharmaceutical Group and Qingping Traditional Chinese Medicine Market, the "Internet+" cluster represented by new medical and healthcare businesses such as 360 Health, Hengjintang, Qiluokang, and Runhe.com, and the medical cluster focusing on biomedicine, and the "Internet+" cluster representing new medical and healthcare business models. Medical Group, Biomedical Group focusing on biomedical R&D and innovation, Medical Device Group with Guangzhou Guoyuan Medical Device City as the main carrier, and Medical and Health Venture Group to carry out incubation of innovative and entrepreneurial enterprises in medicine and health. The major groups are staggered spatially and functionally complementary and supportive of each other, and together with the "one island, one harbor and one belt" constitute the overall pattern of the Comprehensive Pilot Medical and Healthcare Zone.
Medicine and health industry spatial layout map
Second, the main tasks
(a) to give full play to the advantages of the industry, to promote Chinese medicine to take the lead in development
1. Accelerate the modernization and upgrading of Chinese medicine. Promote the integration of Chinese medicine theory and modern science, strengthen the design and optimization of traditional Chinese medicine, pharmaceutical process system control and other modern technology platform construction. Actively seek and participate in the national key equipment for Chinese medicine major special projects, support for Chinese medicine enterprises to use standardization, automation, intelligent technology to transform and upgrade traditional processes. Increase the scientific research of Chinese medicine, product R&D services, R&D of new Chinese medicines and transformation of results, use big data, gene detection technology and other modern technologies, in-depth excavation and deciphering of biased prescriptions, secret prescriptions, and tested prescriptions, and excavate a number of Chinese medicine prescriptions with precise efficacy and characteristic preparations, and build a regional center of traditional Chinese medicines preparations. Relying on Chinese medicine enterprise groups in the region, focusing on targeting cardiovascular and cerebrovascular diseases, tumors, geriatric diseases and sub-health, research and development of original new Chinese medicine varieties with independent intellectual property rights. Create famous brands of traditional Chinese medicine tablets and deepen and refine the American ginseng industry. Promote the construction of Chinese medicine brands, flexibly introduce academicians, national medical masters and national famous Chinese medicine practitioners, build a number of famous Chinese medicine treatment centers and inheritance studios of famous Chinese medicine practitioners, enhance the value of old Chinese medicine brands such as Cai Zhi Lin and Jing Xiu Tang, and improve the series of brands of the "National Medical Hall". The construction of regional Chinese medicine (specialty) diagnosis and treatment centers and major difficult diseases of Chinese and Western medicine clinical collaboration platform, improve the ability of Chinese medicine to solve major disease problems.
2. Enhance the internationalization of Chinese medicine. Promote the construction of the quality evaluation system for the whole industrial chain of Chinese medicine and the authoritative research institution for international standards of Chinese medicine in Guangdong, Hong Kong and Macao Bay Area, and give full play to the influence of the Key Laboratory for Quality Evaluation of Proprietary Chinese Medicines of Guangzhou Pharmaceutical Inspection Institute, which is the only state-level key laboratory in the field of traditional Chinese medicines in Guangdong, Hong Kong and Macao Bay Area, to set up internationally recognized product quality standards of traditional Chinese medicines and to grasp the right to speak on international standards. Jointly with the State Administration of Traditional Chinese Medicine, the Chinese Society of Traditional Chinese Medicine, the International Department of Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine and the International Exchange Center of Guangzhou University of Traditional Chinese Medicine, we will jointly build an International Exchange Center of Traditional Chinese Medicine, which integrates academic exchanges, international cooperation, and training of talents in the internationalization of traditional Chinese medicine. Docking with Hengqin Guangdong-Australia Cooperation in Chinese Medicine Science and Technology Industrial Park, with the state-level quality control base of Chinese medicine and the international health industry exchange platform as the object of cooperation. With the national Chinese medicine quality control base and international health industry exchange platform as the object of cooperation, integrating the advantages of Liwan's Chinese medicine, medical care, education, science and technology industries and Macao's scientific research capabilities and talents, tourism resources, to jointly build the Chinese medicine industry to the world "One Belt, One Road" bridgehead. Support Chinese medicine production and service enterprises in the region to build Chinese medicine overseas trading centers, expand the export of Chinese medicine services, and cultivate new forms and modes of Chinese medicine export. Carry out international medical service quality certification, promote cooperation with international medical insurance companies, etc., Liwan District to build a national Chinese medicine service export base.
3. Create a "Guangdong index" of Chinese herbal medicine prices. The establishment of the Guangdong Provincial Chinese herbal medicine exchange, the construction of the Guangzhou International Medical Port "Guangdong, Hong Kong and Macao Bay Area Internet + Chinese herbal medicine" international trading platform, to create a set of precious and fine Chinese herbal medicine trading and procurement, e-commerce and information query, drug testing and forensics, and Chinese medicine exhibition and other functions as one of the trade and business service centers of traditional Chinese medicine. Linking Puning Chinese herbal medicine professional market, Hengqin Guangdong-Macao Cooperation Chinese Medicine Science and Technology Industrial Park, and Deqing Nanmao Health Industry Base, and establishing a price collection system for Chinese herbal medicine covering the whole country by introducing the six major professional markets for Chinese herbal medicine in China, such as Bozhou of Anhui Province, Anguo of Hebei Province, Hehuachi of Chengdu Province, Yulin of Guangxi Province, Juhu Garden of Kunming Province, and Puning of Guangdong Province and the collection points of the national origins, so as to build a "Guangdong Index" of prices for Chinese herbal medicines together. "Guangdong Index". Provide a basis for pricing, adjusting business varieties, controlling inventory, etc. in the Chinese herbal medicine market, and form a leading role in the national and even global Chinese herbal medicine market. Explore and promote the construction of green Chinese herbal medicine international futures spot trading platform priced in RMB, carry out international and domestic transactions, and strive for international Chinese herbal medicine trading pricing power.
4. Create a global innovation center for Chinese medicine. With the goal of serving the world, we focus on promoting the research and development of modern Chinese medicine and the secondary development of famous and high-quality proprietary Chinese medicines, so as to improve the added value of Chinese medicine products. Focusing on R&D and transformation of results in the areas of protection and development of Chinese medicine resources, Chinese medicine preparation technology, safety evaluation of Chinese medicine injections, and Chinese medicine standards and materials database, it will strengthen the analysis of classical prescriptions and pharmacopoeia data, establish a database of data on symptoms, diseases, diagnosis, prescriptions and medicines in a dialectical and unified manner, and vigorously enhance the capacity for scientific development of traditional Chinese medicine and the ability to provide global services. Support enterprises in the region to strengthen joint research on the prevention and treatment of major difficult diseases and major infectious diseases, as well as research on the prevention and treatment of common, frequent and chronic diseases in TCM, and to form a number of major products and technological achievements in the prevention and treatment of major diseases and the treatment of chronic diseases. Jointly with Jinan University, Hong Kong Baptist University and the University of Macao to build joint laboratories of Guangdong, Hong Kong and Macao and a new R&D organization for modern Chinese medicine, so as to lead international innovation in Chinese medicine. Seek national support for the establishment of the Guangdong-Hong Kong-Macao Greater Bay Area Chinese Medicine New Drug Review Center (Pilot) in the Pilot Area, and establish a new drug review and approval system for Chinese medicine that meets the characteristics of Chinese medicine; allow Chinese medicine products that have been registered and circulating in Hong Kong and Macao for a long period of time, have been proven to be safe and reliable in practice, and are fully recognized by Hong Kong and Macao compatriots, to refer to the registration and management methods of the domestic ancient classical prescriptions, and simplify the process of registering their formulations in the Pilot Area.
5. Expand the Chinese medicine health industry chain. Tap into the integration of tourism resources, traditional Chinese medicine resources and cultural resources, to promote the organic integration of traditional Chinese medicine health services and tourism services, health care, herbal medicine planting demonstration, traditional Chinese medicine culture demonstration, medicinal cuisine, traditional Chinese medicine cosmetology organic combination, to create a strong experience, participation in a wide range of traditional Chinese medicine health tourism brand. To create a special area for health tourism, support leading enterprises of traditional Chinese medicine in the region to carry out pharmaceutical industrial tourism projects, and build a national TCM health tourism demonstration base integrating the production and processing of centralized medicine, health care, promotion of TCM culture and sightseeing tours. The construction of Chinese medicine culture, prevention, health care, rehabilitation, health as the theme of the health park, to explore Chinese medicine dietary services and Chinese medicine tourism professionals training, to carry out Chinese medicine treatment, Chinese medicine health care, Chinese medicine health care, Chinese medicine rehabilitation and other special services.
6. Promote the global dissemination of Chinese medicine culture. Take the Global TCM Conference as a carrier, innovate the discourse system of TCM, build a bridge between Guangdong, Hong Kong and Macao Bay Area and the world's health industry exchanges and cooperation, and establish a unique business card of "Healthy Guangdong". Promote the construction of inheritance and innovation studios for famous and veteran Chinese medicine practitioners, excavate and pass on the academic skills of Chinese medicine, collect and organize folk prescriptions, pass on the techniques of Chinese medicine, and promote the prosperity of Lingnan schools of Chinese medicine in gynecology, acupuncture and moxibustion, orthopedics and pediatrics, and so on. To herbal tea culture, medicinal food culture and other Lingnan characteristics of Chinese medicine culture as an entry point for the construction of experience hall, encourage foreign Chinese medicine enthusiasts to experience hall to learn Chinese medicine, enjoy Chinese medicine services, and jointly promote the dissemination of Chinese medicine culture overseas.
(B) Strengthen the system integration, promote the development of medicine and health industry agglomeration
1. To guide the integration of medicine and health and a new generation of information technology development. To build a demonstration base for the integration of medicine and health and digital science and technology, implement the "medicine and health+digital" integration project and cultivate new forms of medicine and health by focusing on the key application directions of 5G medical care, AI medical care, intelligent research and development of medicines, medical big data, and intelligent medical robots. It will build a national pharmaceutical and healthcare digital service center, accelerate the application of cloud computing, big data, and blockchain technologies in the early research and development of medicines, clinical data analysis of medicines, medical diagnosis and clinical decision support systems, form a leading edge in the integrated development and application of biological data, and accelerate the cultivation and development of digital services such as intelligent medical imaging, intelligent diagnosis and treatment, and intelligent healthcare management. Comprehensively promote the synergistic application of intelligent sensors, big data and other technologies on medical equipment and diagnosis and treatment systems across the region. Support Internet medical enterprises such as Hengjintang and Qilokang to establish a regional "Internet+Medical Health Center" platform, apply new technologies and products such as 5G, Internet of Things and wearable devices, and promote new modes of online medical services. Accelerate the construction of the Siemens Telemedicine Exhibition Center, and improve the functions of product research and development, clinical research, and upstream and downstream industry chain incubation. Construct a regional health information big data center to seize the first opportunity in the integration of new-generation information technology, artificial intelligence and medical and pharmaceutical development. Relying on the Guangzhou 3D Printing Industrial Park, we will vigorously develop precision medicine and support the application of 3D printing research results in the fields of dental and orthopedic surgery simulation, implants and rehabilitation aids.
2. Building an important node in the international pharmaceutical supply chain. Facing the global allocation of resources, strive for the Guangdong Free Trade Zone trade and investment support policies extended to the Guangzhou International Pharmaceutical Port, planning the construction of the Laijiang International Pharmaceutical Port, and the construction of the Laijiang International Pharmaceutical Port. Pharmaceutical port, planning the construction of Liwan pharmaceutical bonded trading center, to carry out import and export trade of drugs, cross-border direct purchase and other businesses. In Guangzhou International Pharmaceutical Port to set up medicine small commodity trading market, Hong Kong and Macao legally listed non-prescription drugs can be sold in the market limit. The development of traditional Chinese medicine - medical equipment - health care products exhibition and trading, innovation and incubation of traditional Chinese medicine, medical and health services and other forms of business, to create a national pharmaceutical industry innovation and incubation base, the headquarters base of the international health industry and the never-ending health industry "Canton Fair". The city will be the center of the medical equipment industry in Guangzhou. Taking Guangzhou Guoyuan Medical Device City as the main carrier, building a medical device registrant commissioned service base, planning and constructing a brand exhibition center, a medical device exhibition and trading center for foreign trade exports, and a display and trading center for rehabilitation household devices and wearable devices for the whole world, attracting global medical device manufacturers and business enterprises to move into the city, and providing one-stop purchasing services for domestic and foreign medical device purchasers and healthcare institutions. Holding the International Health Industry Conference and the International Summit Forum of Chinese Medicine, aiming at the exhibition of new drugs and the centralized purchasing center of drugs to create a new global metropolis in the field of medicine and health. Actively cultivate large-scale multinational pharmaceutical distribution enterprises, and build a modern logistics and distribution center for pharmaceuticals facing the Greater Bay Area and radiating across the country, as well as an important node in the international pharmaceutical supply chain.
3. Develop high-end medical services. With Singapore's leading enterprises to develop Datansha International Health Island, with international high-end medical services as the core, around the service international market and Guangdong, Hong Kong and Macao Greater Bay Area health care needs, the establishment of a functionally complete, seamless, natural and harmonious international high-end health care service base and Lingnan characteristics of the combination of health care leisure resort. Focusing on respiratory specialties, tumor prevention and treatment, stem cell application, plastic surgery and cosmetic surgery, anti-aging, health management, rehabilitation and convalescence, etc., it will closely integrate with clinical practice and develop precision medicine. Accelerate cooperation with internationally renowned medical institutions such as Singapore's Raffles Hospital and ParkwayHealth, and the University of Pittsburgh Medical Center Rehabilitation Hospital in the U.S., and introduce international high-end medical institutions. Promote the establishment of the Guangdong-Hong Kong-Macao Greater Bay Area International Cardiovascular Center with Guangdong Provincial People's Hospital and Greenleaf International Medical Management (Guangzhou). Constructing the "MedicalMall", a consumer medical cluster, introducing international and domestic high-end medical centers specializing in aesthetics, rehabilitation and other specialties, and creating a professional operation carrier for consumer medical care. Strive for the state to allow medical institutions in the pilot zone to provide cutting-edge medical services such as blood purification, functional medicine, stem cell and regenerative medicine, immunotherapy and gene therapy, etc., which have been approved by the competent authorities of developed countries or regions (the European Union, the U.S., Japan, etc.), and to support the entry of mature and reliable cutting-edge medical technologies and advanced medical solutions into clinical application. It will vigorously develop specialty medical services, drive the development of rehabilitation medicine, third-party medical testing and imaging, health management, pension and health care, and build a highland for the development of international medical and health services.
(3) Converge the elements of science and innovation, and promote the innovative development of the pharmaceutical and health industry
1. Construct a platform for pharmaceutical R&D and application. Relying on national, provincial, municipal and district engineering research centers and enterprise R&D institutions in the field of medicine and health, focusing on the modernization of traditional Chinese medicine, life sciences, biotechnology, innovative drugs, biomedical engineering and other innovative frontiers and key technologies to increase innovation. Promote the construction of the National University Science Park of Guangzhou Medical University (Liwan Park), focusing on the direction of innovative medical testing services, medical device creation, innovative drug R & D and sales, innovation and service of traditional Chinese medicine, etc., and strive for the formation of the National Laboratory of Respiratory Health and Life Sciences, and construct a highland of scientific and technological innovation and achievement transformation in the field of acute major respiratory infectious diseases and their related biosafety. Strive for the formation of Zhong Nanshan Academician Team Innovation and Entrepreneurship Base, Innovation Center of Integrative Medicine of Guangzhou Medical University, Innovation and Application Center of Genetic Medicine of Guangzhou Medical University, Precision Medicine Research Institute of Guangzhou Medical University and other platforms. Establish the Guangzhou Chinese Medicine Tablet Industry Industry, University and Research Technology Innovation Union, and carry out the key technology research on the Chinese medicine tablet concoction specification. To build the International Medical Center for Respiratory System, establish a comprehensive preclinical drug safety and efficacy evaluation center featuring respiratory drug evaluation, and create an evaluation system featuring drugs for respiratory diseases, antitumor drugs, cardiovascular diseases, biological drugs, and reagents (drugs) related to precision medicine examination, etc., so as to provide domestic and foreign pharmaceutical enterprises and drug research and development institutes with preclinical drug evaluation services in line with the requirements for drug registration. The company provides preclinical drug evaluation services to domestic and foreign pharmaceutical companies and drug research and development organizations in compliance with drug registration requirements.
2. Enhance the ability of pharmaceutical science and technology innovation. Promote docking and cooperation with China Academy of Traditional Chinese Medicine, Beijing University of Traditional Chinese Medicine and other professional colleges and universities, introduce branches of professional colleges and universities and key laboratories at national and provincial levels, and comprehensively improve the construction of major scientific research facilities and service level. Encourage enterprises in the region to carry out the construction of engineering laboratories, engineering research centers, industrial innovation centers and other new innovation platforms, and enhance the scientific and technological research and development capabilities of enterprises. Support pharmaceutical enterprises to expand the whole industrial chain of R&D, production and sales of high-quality generic drugs, focusing on strengthening the research of key common technologies of generic drugs. Introducing R&D centers of internationally renowned pharmaceutical enterprises, focusing on the R&D of innovative drugs such as gene drugs, protein drugs, monoclonal drugs, therapeutic vaccines, small-molecule chemical drugs and the R&D of biosimilar drugs, and advancing the R&D and application of artificial intelligence-assisted diagnostic technologies, immune cell therapy, stem cell therapy and tumor therapy technologies, as well as new technologies such as gene chip diagnostics. Participate in the construction of China-Japan (Guangzhou) Local Development Cooperation Demonstration Zone, bring together the world's top scientific research institutions in the field of biomedicine and leading talents to Liwan Sub-Park to carry out cutting-edge biotechnology research on new drugs, new medical devices and other cutting-edge biotechnology research, and build a biomedical R&D and scientific and technological achievements transformation system featuring the capital of the pharmaceutical and healthcare industries, with the industry's enterprises as the main body, the market as the guide, and the in-depth integration of the industry, academia and research.
3. Gather high-level innovative talents. Select top talents and teams with international influence and provide continuous and stable support through the establishment of special programs for cutting-edge innovation in medicine and health. Strengthen the services of top talents and teams in the field of medicine and health, and effectively do a good job of supporting medical, education, housing and other aspects of protection. Encourage Hong Kong and Macao medical personnel to carry out academic exchanges, the implementation of technology-based entrepreneurs title assessment "through train" system, and encourage qualified medicine and technology-based entrepreneurs to actively declare. Supporting the construction of inheritance studios for veteran Chinese medicine experts, and strengthening the cultivation of Chinese medicine talents and the inheritance of experience. Promote cooperation with the China Academy of Traditional Chinese Medicine, Beijing University of Traditional Chinese Medicine, the introduction of national Chinese medicine discipline leader, and the formation of discipline development alliance, innovative talent training mode. Establish a system for senior Chinese medicine practitioners to take on apprenticeships, which is linked to the evaluation of titles and the assessment of merits and prizes. Docking with domestic and foreign research institutes, introducing medical and health entrepreneurial talents and entrepreneurial projects, supporting a batch of medical and health industry incubators, and cultivating a batch of innovative and entrepreneurial enterprises. Give full play to the role of various types of talent training platform, focus on training a number of high-quality, high-level management personnel with an international perspective.
(D) deepen external cooperation, support the open development of the pharmaceutical and health industry
1. To create Guangdong, Hong Kong and Macao pharmaceutical and health community Liwan model. Participate in the construction of the Guangzhou-Shenzhen-Hong Kong-Macao Science and Technology Innovation Corridor with the pharmaceutical and healthcare industry as a hand, and cooperate with Hong Kong and Macao in the construction of regional medical consortiums and regional medical centers. Support Hong Kong and Macao medical and health institutions to set up medical institutions in Liwan in the form of sole proprietorship, joint venture or cooperation in accordance with regulations, and facilitate the registration and practice of Hong Kong and Macao physicians. For health food products of Hong Kong and Macao that have been approved for listing in accordance with the law but have not obtained the Mainland's health food registration certificates, they are allowed to be sold in designated institutions in the pilot zone after being authorized to be filed with the Guangdong Provincial Market Supervision Administration. Deepening cooperation with Hong Kong and Macao in the elderly care industry, and supporting Hong Kong and Macao investors to set up elderly care and other social service organizations in Liwan in the form of sole proprietorship, joint venture or cooperation in accordance with regulations. Introduce private capital, attract Hong Kong and Macao capital, and jointly set up a cooperation fund for the elderly care industry. Liwan's advantages in pharmaceutical enterprises, medical and educational support advantages and Hong Kong and Macao's scientific research strength in an orderly manner, to build a "Chinese medicine" + "high-end medical" + "elderly care" + "health education" + "health care" and "health education". "health education" + "health management" industry chain, forming a good situation of complementary functions, industrial linkage and win-win development. Strengthen the linkage development with China-Singapore Guangzhou Knowledge City, and strive for the settlement of its clinical trial base for new drugs in Liwan, so as to form a new medical and healthcare innovation center in Liwan, which is a major medical and healthcare innovation center in China-Singapore Guangzhou Knowledge City. The Sino-Singapore Guangzhou Knowledge City major medical and health innovation R & D results + Datansha International Health City, Guangzhou International Pharmaceutical Port incubation, industrialization of the new situation of cooperation.
2. Expanding the international development space of medicine and health. Build an international cooperation platform, establish a sound dialog mechanism, and strive to promote cooperation in the training of international medical and health care personnel, international innovative drug research and development, and the application of clinical technology. Strengthen cooperation with international organizations such as the United Nations Project Services Agency (UNPSA), and leverage their strengths and influence in project management and global resource integration to provide services for Liwan in project management, international procurement management, global project promotion and resource linkage, and institutional capacity building. Encourage pharmaceutical and healthcare enterprises in the region to "embrace the group to go to sea", enter the "Belt and Road" medical and healthcare projects and participate in the development of the project, support the pharmaceutical trade, pharmaceutical manufacturing and R & D cooperation with the countries along the route, relying on the Internet to carry out long-distance cross-border medical services, and to build a "Belt and Road" medical and healthcare center. Support the development of medical trade, pharmaceutical manufacturing and R&D cooperation with countries along the routes, and carry out remote cross-border medical services based on the Internet, so as to jointly build the "Belt and Road" medical and health ecosystem. Actively carry out international medical research and the introduction of advanced technology, establish commissioned R&D cooperation with internationally renowned medical R&D institutions and innovative drug companies such as Roche, Pfizer, Merck Sharp & Dohme, AstraZeneca, etc., explore new modes of transnational franchising and R&D cooperation, and deepen the research of forward-looking biotherapeutic key technologies, such as targeted gene therapy, cellular therapy, immunotherapy and so on. Build Guangzhou Greenleaf Medical International Hospital, import medical resources from the United States, Australia, Singapore and other countries, and rely on advanced clinical pathways, efficacy evaluation and patient experience design to realize excellent efficacy and patient experience of international standards. Promote the docking of policies with other countries in the medical industry, medical insurance, international currency settlement, customs declaration and inspection and quarantine, diplomatic visas, etc., and strengthen international cooperation in mutual recognition of medical professional and technical qualifications and hospital accreditation, especially the international recognition of Chinese medicine disciplines and qualifications in Chinese medicine, so as to reduce the barriers to trade in foreign medical services.
(V) Comprehensively deepen the reform and create a favorable development environment
1. Build a prudent regulatory mechanism that accommodates innovation. Benchmarking international medicine and health rules and testing regulatory model, docking international medical certification system, to the globally recognized medical services, testing standards and rehabilitation certification system. Support new third-party medical testing and inspection technology development and service model innovation to medical testing, health testing as the core, docking the U.S. FDA and EU CE certification system, to promote the standardization of the third-party medical testing industry normative, standardized development. Formulate specific preventive measures for cross-border investment and financing risks, cross-border capital flow risks, commercial factoring risks and negative list management risks in the pharmaceutical and healthcare industry. For the import and use of drugs and medical devices, strengthen supervision during and after the event to ensure the safety of the use of imported drugs and medical devices. Seek national support to allow the simplification of the approval process for preparations for medical institutions in the pilot zone, and appropriately lower the standards for the development and production of preparations for medical institutions. It is recommended that the State Drug Administration set up a branch in the test area to open a green channel for priority approval of drugs and medical devices for clinical trials in the test area.
2. Optimize the investment and financing system of medicine and health. Optimize the industrial investment environment, in accordance with the principle of "not prohibited is to enter", improve the multi-investment mechanism, and encourage social capital to participate in the establishment of health industry investment funds. Encourage private equity investment and venture capital organizations to carry out services for innovative business, small and micro enterprises in the health industry. Support qualified enterprises to raise capital through multi-channel listing and financing in domestic and overseas capital markets. Explore the international financing model of healthcare enterprises and attract overseas capital intervention. Adopting the platform operation mode of "government guidance + enterprise operation" to establish strategic cooperative relationships with financial investment enterprises, biomedical enterprises, professional consulting and assessment organizations, wealth management companies, etc. to share benefits and risks. Explore the adoption of diversified investment modes such as purchasing intellectual property rights of new drugs and establishing joint ventures with overseas biopharmaceutical companies, so as to provide one-stop services for international innovative drugs and technologies to enter the Chinese market. Encourage and guide all kinds of financial institutions to innovate financial products and services, and increase financial support for the health and pension sectors. Explore the establishment of the Greater Bay Area Pharmaceutical and Health Industry Development Fund to attract a number of top domestic and international venture capital institutions, such as Innovation Works and IDG, to promote the integration of capital resources and industrial resources in the field of medicine and health in the region.
3. Innovate the management mode of pharmaceutical and health care. Strengthen the system design, break the multiple management of resources, separate from each other, and promote the integration of resources and optimization of the layout of medical, pharmaceutical, tourism, pension and other sub-divisions. Further decentralization of government administration, efforts to optimize the government approval process, simplify the project approval process, improve government services, and establish a "green channel" for the approval of key projects in the medical and healthcare industry. We will strengthen precise services, provide registration convenience, implement tax incentives, convenient financing and other services. Enhance the development of medicine and health of the organization and construction capacity to promote the development of medicine and health industry, public health medical system, integrated prevention and control system of viral plague, health city, smart city construction of the integrated construction, the formation of the development of a chessboard, the realization of people's livelihood, urban construction and high-quality economic development of the integration.
Third, safeguard measures
(a) Strengthen the organizational leadership. Establishment of Liwan Medicine Health Comprehensive Pilot Zone work coordination mechanism, research and development of special planning, work programs, systematic deployment of industrial development. Coordinate the study of major issues in the development of medicine and health industry, major policies, coordination of major projects such as planning, project and implementation, and timely research to solve major problems in the development of the industry. All relevant departments to improve the working mechanism, improve the policy support, the development of the implementation of the views, the implementation of the work responsibility, do a good job of coordination, strengthen the elements of protection, the formation of synergies to accelerate the implementation of the program.
(b) strengthen the policy and financial support. Actively to the state and Guangdong Province, Guangzhou City, to fight for the development of medicine and health industry related policies, increase the support for the development of medicine and health industry. Strive to replicate and popularize the policy innovations of Boao Lecheng in Hainan and other domestic medical and healthcare pioneer zones. Make good use of the leverage of government financial funds, pry social capital investment through the innovation of interest mechanism, encourage the development of investment funds that support the construction of key areas and projects in medicine and health, and support the development of equity and debt financing. Strive for further increase in provincial and municipal financial investment, focus on solving the problem of funding sources for major projects, and strengthen the services and guidance for project reporting units. Seek national support for the establishment of a national Chinese medicine international trade fund in the pilot area. Seek provincial support to study the establishment of a provincial-level industrial investment fund for the acceleration of innovative drugs and devices in the pilot zone, and support the establishment of an international platform for the acceleration of innovative drugs (devices) in the pilot zone. Implement the preferential policies on personal income tax in Guangdong, Hong Kong and Macao Greater Bay Area, subsidize eligible high-end talents in short supply from abroad according to the difference in personal income tax burden between the Mainland and Hong Kong, and exempt the subsidies from personal income tax. Provide housing subsidies to eligible high-level talents in short supply in the pharmaceutical and health industry. Support qualified pharmaceutical and health enterprises to enjoy the pre-tax deduction of R&D expenses and other preferential policies on science and technology innovation.
(C) improve the infrastructure. Accelerate the second phase of the Expressway (Dongsha - Shigang Tunnel), Ruyifang Radial System Project, Baigutan Avenue (Huadi River - Chau Tau Tsui Tunnel), Da Tansha Bridge System Project (Baisha River Bridge) and a number of other municipal road construction, and steadily push forward the construction of the subway, dense rail transit network, the formation of a convenient and efficient modern transportation network. Promote the construction of "Three Networks Convergence" and realize the full coverage of 5G wireless network. Improve the construction of public facilities such as education, medical care, culture and municipal infrastructure such as water supply, drainage and flood control, and optimize the living environment for innovative and entrepreneurial talents. To improve the quality of the ecological environment, raise the threshold of access, strengthen the mechanism of environmental assessment and energy assessment, implement more stringent energy conservation and emission reduction standards, vigorously develop low-carbon industries and circular economy, maximize the use of resources and minimize the emission of waste, and promote the development of "three-life integration".
